Managing Cardiac Resynchronization Therapy Nonresponse: Conventional and Unconventional Techniques.
Richard G Trohman1, Henry D Huang1, Ryan M Zimberg1
1Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
Summary
Cardiac resynchronization therapy (CRT) can fail in some heart failure patients. This study explores strategies to improve CRT response in non-responders, offering new hope for better outcomes.
Area of Science:
- Cardiology
- Medical Devices
- Heart Failure Management
Background:
- Cardiac resynchronization therapy (CRT) is a recognized treatment for specific systolic heart failure patients.
- A significant challenge in CRT is the occurrence of nonresponse, limiting its effectiveness.
Observation:
- This study focuses on five patients who did not initially respond to CRT.
- The cases highlight the application of both standard and alternative methods to overcome CRT nonresponse.
Findings:
- Conventional CRT approaches may not suffice for all heart failure patients.
- Nonconventional strategies can be employed to enhance CRT benefits in non-responders.
Implications:
- Optimizing CRT requires a nuanced approach, considering individual patient factors.
- Further research into nonconventional CRT strategies could improve outcomes for non-responders.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
174
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
174
01:30Cardiomyopathy II: Dilated Cardiomyopathy
329
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
329
01:29Cardiomyopathy V: Interprofessional Care
216
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
01:25Dysrhythmias VI: Management of Dysrhythmias
305
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
305
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
416
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
416
01:30Heart Failure V: Medical Management
151
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
151